RWM
AZN icon

RMG Wealth Management’s AstraZeneca AZN Stock Holding History

RMG Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.5K Buy
+129
New +$24.9K ﹤0.01% 218
2025
Q4 		– Sell
-28
Closed -$4.7K – 418
2025
Q3 		$4.7K Hold
28
– – ﹤0.01% 255
2025
Q2 		$3.87K Buy
+28
New +$3.92K ﹤0.01% 265

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

RMG Wealth Management's AZN Position: Q1 2026 in Review

RMG Wealth Management opened a new position in AstraZeneca (AZN) in Q1 2026: 129 shares worth $23.5K. The stake represents ﹤0.01% of the portfolio and ranks #218 among its holdings. This is a return to the name: RMG Wealth Management previously reported a position in AZN as recently as Q3 2025.

RMG Wealth Management first reported a position in AZN in Q2 2025 and has held it in 3 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • RMG Wealth Management held 129 shares of AstraZeneca worth $23.5K as of Q1 2026.
  • AstraZeneca was a new RMG Wealth Management position in Q1 2026.
  • AstraZeneca made up ﹤0.01% of RMG Wealth Management's portfolio in Q1 2026, its #218 holding.
  • RMG Wealth Management first reported a position in AstraZeneca in Q2 2025 and has held it in 3 quarters since.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on RMG Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.